Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses

Katherine Owens1, Shadisadat Esmaeili1, Joshua T Schiffer1,2

  • 1Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA.

JCI Insight
|April 4, 2024
PubMed